source: internationalization/trunk/TranslationSpreadsheets/WV-DIALOG-0235.txt@ 1806

Last change on this file since 1806 was 604, checked in by George Lilly, 15 years ago

Internationalization

File size: 12.1 KB
Line 
1English French Notes Complete/Exclude
2FIRST COURSE OF TREATMENT - RADIATION
338. REGIONAL DOSE (cGy)...........:
439. BOOST DOSE (cGy)..............:
540. INTRA-OPERATIVE RADIATION
641. CONCURRENT CHEMOTHERAPY.......:
7FIRST COURSE OF TREATMENT - CHEMOTHERAPY
842. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:
943. INTRAPERITONEAL CHEMOTHERAPY..:
1044. CHEMOTHERAPEUTIC TOXICITY.....:
1145. CHEMOTHERAPY/SURGERY SEQUENCE.:
12FIRST COURSE OF TREATMENT - IMMUNOTHERAPY
1346. ADMINISTRATION OF INTERFERON..:
14TREATMENT COMPLICATIONS
15CASE REGISTRATION
1648. INITIALS OF CASE ABSTRACTOR...:
1749. DATE CASE WAS ABSTRACTED......:
18The Accession Year is not 2000.
192000 Patient Care Evaluation Study of Hepatocellular Cancers
201. FACILITY ID NUMBER (FIN)
215. PLACE OF BIRTH
226. DATE OF BIRTH
238. SPANISH ORIGIN
2410. PRIMARY PAYER AT DIAGNOSIS
25 1. FACILITY ID NUMBER (FIN)
26 5. PLACE OF BIRTH
27 6. DATE OF BIRTH
28 8. SPANISH ORIGIN
29 1. FACILITY ID NUMBER (FIN)......:
30 2. ACCESSION NUMBER..............:
31 3. SEQUENCE NUMBER...............:
329 4. POSTAL CODE AT DIAGNOSIS......
337 5. PLACE OF BIRTH................
34 6. DATE OF BIRTH.................:
359 8. SPANISH ORIGIN................
3618 10. PRIMARY PAYER AT DIAGNOSIS....
3711. CLASS OF CASE
3813. CONDITIONS PRESENT AT INITIAL DIAGNOSIS
3914. ALCOHOL CONSUMPTION
4015. TUMOR MARKERS
4116. TESTS RELATED TO LIVER FUNCTION
4217. RADIOLOGICAL EVALUATION
4318. DEFINITIVE DIAGNOSIS
4419. DATE OF INITIAL DIAGNOSIS
4522. DIAGNOSTIC CONFIRMATION
46 TUMOR IDENTIFICATION
47 11. CLASS OF CASE.................:
481000 ORAL CONTRACEPTIVES..........
491001 ESTROGEN REPLACEMENT.........
50 13. CONDITIONS PRESENT AT INITIAL DIAGNOSIS:
511012 14. ALCOHOL CONSUMPTION...........
52 15. TUMOR MARKERS:
53 16. TESTS RELATED TO LIVER FUNCTION:
54 17. RADIOLOGICAL EVALUATION:
55 CT ARTERIAL PORTOGRAPHY:
561022 VASCULAR INVASION............
571023 BILOBAR DISEASE..............
581024 LYMPH NODES..................
591025 SIZE OF DOMINANT TUMOR (mm)..
601026 NUMBER OF TUMORS.............
61 SPIRAL CT:
621029 VASCULAR INVASION............
631030 BILOBAR DISEASE..............
641031 LYMPH NODES..................
651032 SIZE OF DOMINANT TUMOR (mm)..
661033 NUMBER OF TUMORS.............
67 INCREMENTAL CT:
681036 VASCULAR INVASION............
691037 BILOBAR DISEASE..............
701038 LYMPH NODES..................
711039 SIZE OF DOMINANT TUMOR (mm)..
721040 NUMBER OF TUMORS.............
731043 VASCULAR INVASION............
741044 BILOBAR DISEASE..............
751045 LYMPH NODES..................
761046 SIZE OF DOMINANT TUMOR (mm)..
771047 NUMBER OF TUMORS.............
781050 VASCULAR INVASION............
791051 BILOBAR DISEASE..............
801052 LYMPH NODES..................
811053 SIZE OF DOMINANT TUMOR (mm)..
821054 NUMBER OF TUMORS.............
831055 18. DEFINITIVE DIAGNOSIS..........
84 19. DATE OF INITIAL DIAGNOSIS.....:
85 22. DIAGNOSTIC CONFIRMATON........:
86 VASCULAR INVASION............: NA
87 BILOBAR DISEASE..............: NA
88 LYMPH NODES..................: NA
89 SIZE OF DOMINANT TUMOR (mm)..: Not performed
90 NUMBER OF TUMORS.............: Not performed
91 VASCULAR INVASION............: Unknown
92 BILOBAR DISEASE..............: Unknown
93 LYMPH NODES..................: Unknown
9423. SIZE OF TUMOR
9524. REGIONAL NODES EXAMINED
9625. REGIONAL NODES POSITIVE
9726. AJCC CLINICAL STAGE (cTNM)
9827. AJCC PATHOLOGIC STAGE (pTNM)
9928. STAGED BY
100 STAGE OF DISEASE AT DIAGNOSIS
10129 23. SIZE OF TUMOR ................
10233 24. REGIONAL NODES EXAMINED.......
10332 25. REGIONAL NODES POSITIVE.......
104 26. AJCC CLINICAL STAGE (cTNM):
10537.1 AJCC CLINICAL T..............
10637.2 AJCC CLINICAL N..............
10737.3 AJCC CLINICAL M..............
108 27. AJCC PATHOLOGIC STAGE (pTNM):
10985 AJCC PATHOLOGIC T............
11086 AJCC PATHOLOGIC N............
11187 AJCC PATHOLOGIC M............
112 28. STAGED BY:
11319 CLINICALLY STAGED BY.........
11489 PATHOLOGICALLY STAGED BY.....
11529. DATE OF FIRST COURSE OF TREATMENT
11630. DATE OF INPATIENT ADMISSION
11731. DATE OF INPATIENT DISCHARGE
11832. DATE OF NON CANCER-DIRECTED SURGERY
11933. NON CANCER-DIRECTED SURGERY
12034. DATE OF CANCER-DIRECTED SURGERY
12135. SURGICAL APPROACH
12236. SURGERY OF PRIMARY SITE
12337. RADIO-FREQUENCY DESTRUCTION OF TUMOR
12439. SURGICAL MARGINS
12540. DISTANCE OF TUMOR TO CLOSEST MARGIN
12641. SURGERY OF REGIONAL SITE(S), DISTANT SITE(S), OR DISTANT LYMPH NODE(S)
12742. SURGICAL TREATMENT OF RESIDUAL PRIMARY TUMOR
12843. RECONSTRUCTION/RESTORATION-FIRST COURSE
12944. DATE RADIATION STARTED
13045. RADIATION THERAPY
13146. DATE CHEMOTHERAPY STARTED
13248. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED
13349. ROUTE CHEMOTHERAPY ADMINISTERED
13450. CHEMOTHERAPY/SURGERY SEQUENCE
135OTHER THERAPY
13651. DATE OTHER TREATMENT STARTED
13752. OTHER TREATMENT
13853. ARTERIAL EMBOLIZATION
13954. DEATH WITHIN30 DAYS OF START OF INTIIAL COURSE OF THERAPY
140 FIRST COURSE OF TREATMENT
141 29. DATE OF FIRST COURSE OF
1421 30. DATE OF INPATIENT ADMISSION...
1431.1 31. DATE OF INPATIENT DISCHARGE...
144 32. DATE OF NON CANCER-DIRECTED
145 33. NON CANCER-DIRECTED SURGERY...:
146 34. DATE OF CANCER-DIRECTED
147 35. SURGICAL APPROACH.............:
148 36. SURGERY OF PRIMARY SITE.......:
149 37. RADIO-FREQUENCY DESTRUCTION OF
1501056 37. RADIO-FREQUENCY DESTRUCTION OF TUMOR........................
151 38. ABLATION & RESECTION..........: Ablation & resection not administered
152 39. SURGICAL MARGINS..............:
153 40. DISTANCE OF TUMOR TO CLOSEST
1541058 40. DISTANCE OF TUMOR TO CLOSEST MARGIN.......................
155 41. SURGERY OF OTHER REGIONAL
156 SITE(S), DISTANT SITE(S),
157 OR DISTANT LYMPH NODE(S).....:
158 42. SURGICAL TREATMENT OF RESIDUAL PRIMARY TUMOR:
159 FIRST COURSE.................:
160 44. DATE RADIATION STARTED........:
161 45. RADIATION THERAPY.............:
162 46. DATE CHEMOTHERAPY STARTED.....:
163 48. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:
164 CISPLATIN....................: Unknown if recommended or administered
165 FUDR.........................: Unknown if recommended or administered
166 5-FU.........................: Unknown if recommended or administered
167 FU & LEUCOVORIN..............: Unknown if recommended or administered
168 IRINOTECAN (CPT-11)..........: Unknown if recommended or administered
169 MITOMYCIN C..................: Unknown if recommended or administered
170 OXALIPLATIN..................: Unknown if recommended or administered
171 GEMCITABINE..................: Unknown if recommended or administered
172 49. ROUTE CHEMOTHERAPY ADMIN......: NA
1731069 49. ROUTE CHEMOTHERAPY ADMIN
174 50. CHEMOTHERAPY/SURGERY SEQUENCE.: No chemotherapy and/or no surgery
175 50. CHEMOTHERAPY/SURGERY SEQUENCE.: Chemotherapy before surgery
1761070 50. CHEMOTHERAPY/SURGERY SEQUENCE.
177 OTHER THERAPY
178 51. DATE OTHER TREATMENT STARTED..:
179 52. OTHER TREATMENT...............:
1801071 53. ARTERIAL EMBOLIZATION.........
1811072 54. DEATH WITHIN 30 DAYS OF START OF INITIAL COURSE OF THERAPY.
18255. DATE OF FIRST RECURRENCE
18356. TYPE OF FIRST RECURRENCE
18455. TYPE OF FIRST RECURRENCE
18556. DATE OF FIRST RECURRENCE
18670 55. DATE OF FIRST RECURRENCE
18771 56. TYPE OF FIRST RECURRENCE
18857. DATE OF LAST CONTACT OR DEATH
18958. VITAL STATUS
19059. CANCER STATUS
191 57. DATE OF LAST CONTACT OR DEATH..:
19215 58. VITAL STATUS...................
193 59. CANCER STATUS..................:
194 1. FACILITY ID NUMBER (FIN)....:
195 2. ACCESSION NUMBER............:
196 3. SEQUENCE NUMBER.............:
197 4. POSTAL CODE AT DIAGNOIS.....:
198 5. PLACE OF BIRTH..............:
199 6. DATE OF BIRTH...............:
200 8. SPANISH ORIGIN..............:
20110. PRIMARY PAYER AT DIAGNOSIS..:
202TUMOR IDENTIFICATION
20311. CLASS OF CASE...............:
204 ORAL CONTRACEPTIVES........:
205 ESTROGEN REPLACEMENT.......:
20614. ALCOHOL CONSUMPTION.........:
20715. TUMOR MARKERS:
20816. TESTS RELATED TO LIVER FUNCTION:
209 CT ARTERIAL PORTOGRAPHY:
210 VASCULAR INVASTION.........:
211 BILOBAR DISEASE............:
212 LYMPH NODES................:
213 SIZE OF DOMINANT TUMOR (MM):
214 NUMBER OF TUMORS...........:
215 SPIRAL CT:
216 INCREMENTAL CT:
21718. DEFINITIVE DIAGNOSIS........:
21819. DATE OF INITIAL DIAGNOSIS...:
21922. DIAGNOSTIC CONFIRMATION.....:
220Print Hepatocellular Cancer PCE
221STAGE OF DISEASE AT DIAGNOSIS
22223. SIZE OF TUMOR...............:
22324. REGIONAL NODES EXAMINED.....:
22425. REGIONAL NODES POSITIVE.....:
22526. AJCC CLINICAL STAGE (cTNM):
226 AJCC CLINICAL T............:
227 AJCC CLINICAL N............:
228 AJCC CLINICAL M............:
229 AJCC CLINICAL STAGE GROUP..:
23027. AJCC PATHOLOGIC STAGE (pTNM):
231 AJCC PATHOLOGIC T..........:
232 AJCC PATHOLOGIC N..........:
233 AJCC PATHOLOGIC M..........:
234 AJCC PATHOLOGIC STAGE GROUP:
23528. STAGED BY:
236 CLINICALLY STAGED BY.......:
237 PATHOLOGICALLY STAGED BY...:
238FIRST COURSE OF TREATMENT
23929. DATE OF FIRST COURSE OF
24030. DATE OF INPATIENT ADMISSION.:
24131. DATE OF INPATIENT DISCHARGE.:
24232. DATE OF NON CANCER-DIRECTED
24333. NON CANCER-DIRECTED SURGERY.:
24434. DATE OF CANCER-DIRECTED
24535. SURGICAL APPROACH...........:
24636. SURGERY OF PRIMARY SITE.....:
24737. RADIO-FREQUENCY DESTRUCTION
248 OF TUMOR...................:
24939. SURGICAL MARGINS............:
25040. DISTANCE OF TUMOR TO CLOSEST
25141. SURGERY OF OTHER REGIONAL
252 OR DISTANT LYMPH NODE(S)...:
253 FIRST COURSE...............:
25444. DATE RADIATION STARTED......:
25545. RADIATION THERAPY...........:
25646. DATE CHEMOTHERAPY STARTED...:
25749. ROUTE CHEMOTHERAPY ADMIN....:
25850. CHEMOTHERAPY/SURGERY SEQ....:
25951. DATE OTHER TREATMENT STARTED:
26052. OTHER TREATMENT.............:
26153. ARTERIAL EMBOLIZATION.......:
26254. DEATH WITHIN 30 DAYS OF
263 START OF INITIAL COURSE OF
26455. DATE OF FIRST RECURRENCE....:
26556. TYPE OF FIRST RECURRENCE....:
26657. DATE OF LAST CONTACT/DEATH..:
26758. VITAL STATUS................:
26859. CANCER STATUS...............:
269The Class of Case code is not 0, 1, 2 or 5.
270The Behavior Code is not 0, 1 or 3.
271 2000 Patient Care Evaluation Study of Primary Intracranial & CNS Tumors
2722000 Patient Care Evaluation Study of Primary Intracranial & CNS Tumors
27310. PRIOR EXPOSURE TO RADIATION
27411. PRIMARY PAYER AT DIAGNOSIS
27512. PRIOR MEDICAL CONDITIONS
27614. GENETIC PREDISPOSITION
27715. USUAL OCCUPATION
27816. USUAL INDUSTRY
279 5. DATE OF BIRTH.................:
2809 7. SPANISH ORIGIN................
281403 10. PRIOR EXPOSURE TO RADIATION...
28218 11. PRIMARY PAYER AT DIAGNOSIS....
283 12. PRIOR MEDICAL CONDITIONS:
2841202 MULTIPLE SCLEROSIS (MS)......
285354 MYOCARDIAL INFARCTION (MI)...
2861204 CEREBROVASCULAR DISEASE......
2871208 MALIGNANT MELANOMA...........
2881209 OTHER SKIN CANCER............
2891211 COLON OR OTHER GI CANCERS....
290 14. GENETIC PREDISPOSITION:
2911214 VON HIPPEL-LINDAU DISEASE....
2921215 TUBEROUS SCLEROSIS...........
2931216 TURCOT SYNDROME..............
2941217 LI-FRAUMENI SYNDROME.........
2951218 KOWDEN DISEASE...............
2961219 NEVOID BASAL CELL CARCINOMA..
297 15. USUAL OCCUPATION..............:
298 16. USUAL INDUSTRY................:
29917. CLASS OF CASE
30019. NEUROLOGICAL FINDINGS
30120. PRE-THERAPY DIAGNOSTIC STUDIES
30221. TUMOR LOCATION/INVOLVEMENT
303#################### #################### ####################
304#################### #################### ####################
305#################### #################### ####################
306#################### #################### ####################
307#################### #################### ####################
Note: See TracBrowser for help on using the repository browser.